These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25982015)

  • 1. Safe MRI in Patients With an Upgraded (Conditional) Implantable Cardioverter-Defibrillator: The Beneficial Tip of a Troublesome Iceberg.
    Moss AJ; Kutyifa V
    J Am Coll Cardiol; 2015 Jun; 65(24):2589-2590. PubMed ID: 25982015
    [No Abstract]   [Full Text] [Related]  

  • 2. Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study.
    Gold MR; Sommer T; Schwitter J; Al Fagih A; Albert T; Merkely B; Peterson M; Ciuffo A; Lee S; Landborg L; Cerkvenik J; Kanal E;
    J Am Coll Cardiol; 2015 Jun; 65(24):2581-2588. PubMed ID: 25982014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote Monitoring and Outcomes in Pacemaker and Defibrillator Patients: Big Data Saving Lives?
    Freeman JV; Saxon L
    J Am Coll Cardiol; 2015 Jun; 65(24):2611-2613. PubMed ID: 25983010
    [No Abstract]   [Full Text] [Related]  

  • 4. Image Quality of Cardiac Magnetic Resonance Imaging in Patients With an Implantable Cardioverter Defibrillator System Designed for the Magnetic Resonance Imaging Environment.
    Schwitter J; Gold MR; Al Fagih A; Lee S; Peterson M; Ciuffo A; Zhang Y; Kristiansen N; Kanal E; Sommer T;
    Circ Cardiovasc Imaging; 2016 May; 9(5):. PubMed ID: 27151268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance imaging in patients with pacemakers and implantable cardioverter-defibrillators: a systematic review].
    Martins RP; Baruteau AE; Treguer F; Césari O; Carsin-Nicol B; Langella B; Leclercq C; Daubert JC; Mabo P
    Ann Cardiol Angeiol (Paris); 2010 Aug; 59(4):221-8. PubMed ID: 19962691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of implantable cardioverter-defibrillator developed for magnetic resonance imaging use.
    Gold MR; Kanal E; Schwitter J; Sommer T; Yoon H; Ellingson M; Landborg L; Bratten T
    Heart Rhythm; 2015 Mar; 12(3):631-638. PubMed ID: 25496984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging in patients with a subcutaneous implantable cardioverter-defibrillator.
    Keller J; Neužil P; Vymazal J; Janotka M; Brada J; Žáček R; Vopálka R; Weichet J; Reddy VY
    Europace; 2015 May; 17(5):761-6. PubMed ID: 25687749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Difficult AV optimization in a patient with a biventricular implantable cardioverter defibrillator].
    Israel CW; Ehrlich JR; Britten M
    Herzschrittmacherther Elektrophysiol; 2006 Sep; 17(3):174-9. PubMed ID: 16969731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A literature review: Advance directives and patients with implantable cardioverter defibrillators.
    Conelius J
    J Am Acad Nurse Pract; 2010 May; 22(5):250-5. PubMed ID: 20500739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of distressed (Type D) personality and shocks in patients with an implantable cardioverter defibrillator.
    Denollet J; Tekle FB; Pedersen SS; van der Voort PH; Alings M; van den Broek KC
    Int J Cardiol; 2013 Sep; 167(6):2705-9. PubMed ID: 22809538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct intracardiac placement of an automatic implantable cardioverter defibrillator coil lead in a small child.
    Kantoch MJ; Rebeyka IM; Houlden LA; Dyck JD
    Europace; 2007 Aug; 9(8):669-71. PubMed ID: 17468297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter defibrillator.
    Mickleborough LL
    Adv Card Surg; 1994; 5():209-30. PubMed ID: 8118593
    [No Abstract]   [Full Text] [Related]  

  • 14. Arrhythmogenic right ventricular dysplasia and the implantable cardioverter-defibrillator: a case report and review of the literature.
    Cohen TJ; Zadeh H; Fruauff A; Klein J
    J Invasive Cardiol; 2000 Aug; 12(8):422-4. PubMed ID: 10953107
    [No Abstract]   [Full Text] [Related]  

  • 15. Discrepancies in the U.S. and European guidelines involving the implantable cardioverter-defibrillator and cardiac resynchronization therapy: Need for a single shared international publication.
    Kutyifa V; Cannom D; Klein HU; Moss AJ
    Heart Rhythm; 2017 Apr; 14(4):474-475. PubMed ID: 28064030
    [No Abstract]   [Full Text] [Related]  

  • 16. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
    Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
    Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death].
    Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE
    Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
    Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
    J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of sudden cardiac death: from wearable to subcutaneous cardioverter defibrillator.
    Viani S; Soldati E; DI Cori A; Segreti L; Paperini L; DE Lucia R; Zucchelli G; Bongiorni MG
    Minerva Cardioangiol; 2018 Feb; 66(1):83-99. PubMed ID: 28696089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.